Test for post-vaccination evaluation of IgG for erectile encephalitis

The aim of this study is to assess the immune response of the patient to EHV after vaccination. The test focuses on measuring the level of IgG antibodies, as these antibodies are produced in the body in response to infection or vaccination. This is an important step in determining whether the vaccination has triggered an adequate immune response that could protect against encephalitis.

The test will assess the level of IgG antibodies in the patient's blood sample to determine whether they are high enough to provide protection against the Ebola virus. This test may be important to make sure that the vaccination has triggered an adequate immune response, which would be important for the patient's health and protection from the disease.